anti-BCMA/GPRC5D CAR-T cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-BCMA/GPRC5D CAR-T cell therapy, covering 2022-08-22 to 2022-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM) [Phase 2]